- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01984216
Billroth II Versus Roux-en-Y for the Gastrojejunostomy in the Pancreatoduodenectomy
August 26, 2016 updated by: Fundacion Miguel Servet
Billroth II Versus Roux-en-Y for the Gastrojejunostomy Reconstruction in the Pancreatoduodenectomy: a Randomized Controlled Study
The purpose of this study is to compare the safety and superiority of Roux-Y versus Billroth II gastrojejunostomy reconstruction on delayed gastric emptying after pancreatoduodenectomy.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Navarre
-
Pamplona, Navarre, Spain, 31008
- Complejo Hospitalario de Navarra
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Consecutive series of patients undergoing pancreaticoduodenectomy (PD).
- Given informed consent.
Exclusion Criteria:
- Inability to perform pancreatogastrostomy.
- Resection of other organs, except the superior mesenteric-portal vein.
- Previous gastric surgery.
- Preoperative gastric or duodenal obstruction.
- Previous complex abdominal surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Roux-en-Y
Roux-en-Y for the gastrojejunostomy reconstruction
|
|
|
Active Comparator: Billroth II
Billroth II for the gastrojejunostomy reconstruction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of delayed gastric emptying (DGE)
Time Frame: 30 day after surgery
|
30 day after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Francisco Javier Herrera, MD, Complejo Hospitalario de Navarra
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2013
Primary Completion (Actual)
August 1, 2016
Study Completion (Actual)
August 1, 2016
Study Registration Dates
First Submitted
November 7, 2013
First Submitted That Met QC Criteria
November 7, 2013
First Posted (Estimate)
November 14, 2013
Study Record Updates
Last Update Posted (Estimate)
August 29, 2016
Last Update Submitted That Met QC Criteria
August 26, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- CIRUGIA-CHN
- 2013-000693-30 (EudraCT Number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatoduodenectomy
-
University Hospital, MontpellierUniversité MontpellierCompletedPancreatoduodenectomy
-
Changhai HospitalCompleted
-
Peking Union Medical College HospitalUnknown
-
Institut d'Investigació Biomèdica de Girona Dr....RecruitingPostoperative Pancreatic Fistula Post-pancreatoduodenectomySpain
-
The Cleveland ClinicEthicon, Inc.RecruitingPancreatoduodenectomy | Whipple ProcedureUnited States
-
Wakayama Medical UniversityUnknownPatients Who Undergo PancreatoduodenectomyJapan
-
Linkoeping UniversityLandspitali University HospitalCompletedPancreatectomy | Pancreatoduodenectomy | Distal Pancreatectomy (DP)
-
Institute of Liver and Biliary Sciences, IndiaCompletedPancreatoduodenectomyIndia
-
Technische Universität DresdenCompleted
-
Fudan UniversityRecruitingPancreatic Cancer | Periampullary Carcinoma | PancreatoduodenectomyChina
Clinical Trials on Roux-en-Y for the gastrojejunostomy reconstruction
-
The First Affiliated Hospital with Nanjing Medical...Unknown
-
National Taiwan University HospitalUnknown
-
Jilin UniversityUnknown
-
Yonsei UniversityUnknownDiabetes | Gastric CancerKorea, Republic of
-
Fudan UniversityUnknown
-
Korea University Guro HospitalSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Seoul National University Bundang Hospital and other collaboratorsCompleted
-
Gangnam Severance HospitalCompletedGastric Cancer | Diabetes Mellitus Type 2 in NonobeseKorea, Republic of
-
Wakayama Medical UniversityUnknownPancreatic Neoplasms | Pancreatitis | Bile Duct Neoplasms | Duodenal Neoplasms | Ampullary NeoplasmsJapan
-
Ajou University School of MedicineUnknownGastrectomyKorea, Republic of
-
Kyungpook National University Chilgok HospitalCompletedDiabetes Mellitus, Type 2 | Stomach NeoplasmKorea, Republic of